DuPont hosts ‘Health by Design’ Symposium in Mumbai, Hyderabad
Industry experts gave insights on what they expectations from excipient manufacturers
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
DRL launches chlorthalidone tablets, USP in the US market
The tablets are available in 25 mg tablets in the bottle-count sizes of 100 and 1000, and 50 mg tablets
Zebrafish help unlock mystery of motor neurone disease
Trialing 1,000 drugs on mice models would take more than 10 years, however trialling 1,000 drugs on zebrafish would take only a…
Sun Pharma settles Modafinil antitrust litigation
The company, however, did not disclose the details of the settlement, saying the terms are confidential
Alembic Pharma gets US FDA approval for insomnia treatment drug
The approved abbreviated new drug application (ANDA) is the therapeutic equivalent to the reference listed drug product (RLD)…
NIPER-SMPIC along with IPA (Delhi Branch) conducts seminar on impurity profiling
Around 55 personnel from the industry and students from various institutes attended the workshop
Alembic Pharma gets US FDA nod for Xylocaine pain relief ointment
Xylocaine ointment, used for temporary relief of pain associated with minor burns, including sunburn, abrasions of the skin and…
Sun Pharma to acquire Pola Pharma in Japan
Acquisition to help in building global dermatology business
SPARC announces top-line results of Pivotal Bioequivalence Study
With the launch of novel formulations, market for nano-formulations of Paclitaxel is expected to grow
Glenmark receives tentative ANDA approval for Clobetasol Propionate Foam
The company continues to identify and explore external development partnerships to supplement and accelerate the growth
Canadian delegation to showcase investment opportunities to India
The delegation will visit Bengaluru and Mumbai from November 26 to 30
Lupin launches chatbot ANYA
ANYA is the first bot of its kind to be launched in India for disease awareness
ABLE’s BioEconomy Conclave to be held in Bengaluru
The two-day conclave from January 31 to Febrauary 1, will have nine sessions dedicated to different segments of bioeconomy
Strides board approves $15 m investment in Stelis Biopharma
The first close of the current fund raise is $35 million, of which Strides will commit $15 million and $20 million is from other…
Roche-AbbVie cancer drug gets accelerated FDA approval
The drug, developed in partnership with AbbVie, was approved for patients with acute myeloid leukemia
US FDA approves new blood cancer treatment from Pfizer
The company plans to launch the drug, Daurismo, in the US by early December with a monthly list price of $16,925
Indoco’s Goa Plant II & III clears US FDA inspection
This positive development will now pave the way for approval of our pending ANDAs with consequent boost to revenues from the US…
Environmental exposures early in life modify immune responses
Studies have shown that immunological development and maturation starts already during pregnancy and in early childhood
Glenmark receives ANDA approval for Atovaquone Oral Suspension USP, 750 mg/5 mL
The drug is the generic version of Mepron 1 Oral Suspension, 750 mg/5 mL, of GlaxoSmithKline
Piramal Pharma Solutions unveils cGMP kilo lab suite for API
The suite in Chennai will formally open on December 1, 2018